Engineering in Medicine Symposium - Participant Biographies
Pamela Bagley is a Research and Education Librarian at Dartmouth Biomedical Libraries. She regularly teaches evidence based practice principles to medical students and clinicians. In 2006, she participated in the "Workshop on Evidence Based Practice" at the Oxford Centre for Evidence-Based Practice. Pamela has participated on the planning committee and as a faculty librarian in the annual three-day "Dartmouth Summer Institute in Evidence-Based Psychiatry and Mental Health" since it began in 2006. She also participated on the planning committee and as faculty for "Supporting Clinical Care: An Institute in Evidence-Based Practice for Medical Librarians" held in August, 2008. In March, 2008 she spent ten days giving talks and leading workshops and hands-on sessions for clinicians at the National Children's Hospital in Hanoi, Vietnam. Pamela's background as a research scientist gives her extensive experience in designing, evaluating and appraising research studies.
Paul B. Batalden, M.D., is the Director of the Center for Leadership and Improvement at The Dartmouth Institute for Health Policy and Clinical Practice (formerly the Center for the Evaluative Clinical Sciences) and Professor of Pediatrics and of Community and Family Medicine at Dartmouth Medical School. Dr. Batalden leads the creation and delivery of educational opportunities for physicians, nurses, healthcare workers, healthcare administrators and their teachers about the improvement of the quality, value and safety of health care. He is the Program Director of the Dartmouth-Hitchcock Leadership Preventive Medicine Residency program, which is a residency program that combines a specialty residency with the Leadership Preventive Medicine residency at Dartmouth-Hitchcock Medical Center. He co-directs the Veteran's Administration National Quality Scholars program--a two-year special fellowship for physicians who have completed their specialty training and who wish to become teachers and researchers in the improvement of the quality, safety and value of health care. Dr. Batalden also serves as the Senior Vice-President for Health Professional Development of the Institute for Healthcare Improvement, a position he took after serving as the founding chairman of the IHI Board. He is the Chair of the IHI Health Professions Education Collaborative whose aim is to prepare health professionals to lead the continual improvement of the quality, safety and value of health care. Dr. Batalden is the Project Director of the Robert Wood Johnson Foundation Publication Guidelines Grant (SQUIRE).
John Collier, D.E., is the Myron Tribus Professor of Engineering at Thayer School of Engineering at Dartmouth. He is a member of the Society for Biomaterials, the Orthopaedic Research Society and the American Academy of Orthopaedic Surgeons. Collier has been a research consultant for Canadian Oxygen, Ltd., DuPont Inc., and for DePuy, a Johnson and Johnson company. He has authored over 30 technical articles and delivered more than 50 conference presentations on aspects of orthopedic implant design and engineering. He also holds three patents for design or processes relating to orthopedic prostheses. His laboratory focuses on analysis and development of biomaterials for use in bone and joint implants.
Dr. Collier received his Bachelor of Arts from Dartmouth College, 1972, B.E. from Thayer School of Engineering in 1973, and M.S. and Doctor of Engineering at Thayer School of Engineering. At Thayer School he teaches the School's signature course, ENGS 21: Introduction to Engineering, as well as other courses in design methodology and biomaterials.
Joyce A. DeLeo, Ph.D., is Professor and Chair of Pharmacology and Toxicology at the Dartmouth Medical School. She is currently the Irene Heinz Given Endowed Professor and Chair of Pharmacology and Toxicology. She was a member of the 2001-2002 Class of Fellows in the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program and received the first annual Graduate Faculty Mentoring Award from the Office of Graduate Studies, Dartmouth College in 2004. Dr. DeLeo has been instrumental in developing and directing the Neuroscience Center at Dartmouth, an interdisciplinary group whose mission is to foster collaborative and interactive research and education in the neurosciences. Dr. DeLeo was actively involved in the development of the recently established interdisciplinary graduate program, the Program in Experimental and Molecular Medicine (PEMM). The mission of Dr. DeLeo's laboratory is to better understand central nervous system and neuroimmune mechanisms that lead to chronic pain including neuropathic, inflammatory, post-operative and low back pain. This knowledge will translate into development of new, effective approaches for treatment and even prevention of these chronic pain syndromes. Dr. DeLeo serves on numerous NIH study sections, international grant review boards and editorial boards and has published over 130 peer-reviewed manuscripts, reviews and chapters.
Dr. DeLeo received her B.S. in Biology and Chemistry from the State University of New York at Albany in 1982 and a Ph.D. in Pharmacology from the University of Oklahoma Health Sciences Center in 1988. She did much of her pre-doctoral research at the Max Planck Institute of Psychiatry in Martinsried, W. Germany under a Fulbright scholarship investigating the effect of cerebral ischemia on an electrophysiological hippocampal slice preparation and the pharmacological intervention of in vivo ischemia. Dr. DeLeo did a post-doctoral fellowship at Harvard University, Department of Neuroscience, where she studied neonatal hypoxia and seizure susceptibility. She then came to Dartmouth as a post-doctoral fellow in the Anesthesia Research Laboratory.
Tillman Gerngross, Ph.D., is a Professor of Bioengineering at the Thayer School of Engineering at Dartmouth College and an Adjunct Professor in the Department of Biology and Chemistry at Dartmouth. Gerngross has been an active inventor and to date his work has resulted in the founding of two companies (GlycoFi, Inc. and Adimab, Inc.) and over a dozen U.S. and International patents. His work has been frequently cited in the popular press including The Times (London), CNN, Scientific American, BBC, The Guardian, The Economist, New Scientist, Nature Biotechnology and the Los Angeles Times. He joined the faculty at Dartmouth in 1998 with a research focus on protein engineering, glycoprotein engineering in yeast, and life cycle analysis of competing manufacturing technologies. Gerngross developed a method for humanizing the glycosylation machinery in yeast to produce human therapeutic proteins, including antibodies, with fully human carbohydrate structures. Much of this work was conducted at Glycofi, Inc., a Lebanon, New Hampshire biotechnology startup company that was acquired in 2006 by Merck in a record-setting $400 million transaction.
Gerngross received a M.S. (Dipl. Ing.) in Chemical Engineering (1989) and later a Ph.D. in Molecular Biology from the Technical University of Vienna, Austria. Following his studies in Austria he became a visiting scientist at the Massachusetts Institute of Technology (Cambridge, MA) in the laboratory of Arnold Demain (1989-91) and later joined the laboratory of Anthony Sinskey and Joanne Stubbe at MIT as a Postdoctoral Associate from 1991 to 1993. From 1993 till 1998 he headed the fermentation and process development group at Metabolix Inc., a small startup company in Cambridge, MA.
Ashifi Gogo's venture into social entrepreneurship has continuously enjoyed a strong link with academia. At Whitman College on a full scholarship, Ashifi majored in mathematics and physics. Seeking a closer experience in implementing scientific solutions with a focus on the developing world, he entered Dartmouth College to pursue a Ph.D. in engineering with an emphasis on communication systems. At Dartmouth, he earned an Albert Schweitzer Fellowship by virtue of social enterprise, and honed his professional acumen with Six Sigma Black Belt training. Awards from the University of Washington, Seattle, the Claudio Chiuchiarelli Foundation, the Hong Kong University of Science and Technology and acceptance as a Fellow into America's first doctoral-level innovation program in recognition of technology-driven social enterprise have stimulated him towards excellence. As a co-founder and Chief Technologist of mPedigree, Gogo currently oversees the rollout of an innovative West-African drug quality assurance network that leverages the explosive growth of mobile phones in developing nations, allowing any consumer with a cell phone to verify the genuineness of medication before use, at no cost.
Karl Griswold, Ph.D., is an Assistant Professor of Bioengineering at the Thayer School of Engineering at Dartmouth College and an Adjunct Assistant Professor in the Department of Biological Sciences at Dartmouth. Karl's work in the field of combinatorial protein engineering has resulted in the development of novel strategies for gene library construction and new approaches to high throughput screening of recombinant enzyme libraries. At the Thayer School, his research group is seeking to develop and utilize tools for evolutionary protein engineering while placing a priority on designing therapeutic enzymes with practical utility in treating human disease. In August of 2008, he received a Wallace H. Coulter Foundation Early Career Translational Research Award in Biomedical Engineering for research relating to development of enzymatic antibacterial therapies.
Karl studied as a DOW Foundation Scholar at Texas State University, earning a B.S. in chemistry in 1995. After working for two years with Thermo Electron Corporation and two years with Huntsman Corporation, he returned to academia receiving a Ph.D. in chemistry from the University of Texas at Austin in 2005. He then worked as a postdoctoral fellow with George Georgiou in the department of chemical engineering before joining the Thayer School of Engineering faculty in June of 2007.
Joseph J. Helble, Ph.D., is Professor of Engineering and the 12th Dean of the Thayer School of Engineering at Dartmouth College. Prior to joining Dartmouth in 2005, Dr. Helble was the Roger Revelle Fellow of the American Association for the Advancement of Science (AAAS), enabling him to spend an academic year addressing technology and environmental policy issues in the office of U.S. Senator Joe Lieberman.
Previously, Dr. Helble was a member and later chair of the Department of Chemical Engineering at the University of Connecticut, with research in the areas of air pollution, CO2 capture, aerosols, and nanoscale materials production. He also initiated what has become a campus-wide program to produce biodiesel fuel from waste vegetable oil. From 1987-1995, he was employed as a research scientist and manager at Physical Sciences Inc. in Andover MA, specializing in environmental and energy technology development. In 1993, he also worked at U.S. EPA headquarters in Washington DC as a science and policy fellow of AAAS.
Dr. Helble has served on several EPA Science Advisory Board panels, and is presently on the editorial boards of two scientific journals. He is also a member of the Board of Advisors of the University of Vermont College of Engineering and Mathematical Sciences. Dr. Helble is the author of over 100 publications in the areas of air pollution, aerosols, nanoscale ceramics, and air quality, and 3 U.S. patents related to nanoscale powder production. He was a recipient of a young faculty Career Award from NSF, an outstanding young faculty award from the University of Connecticut School of Engineering, and the inaugural environmental faculty leadership award from the University of Connecticut.
Dr. Helble is a 1982 summa cum laude chemical engineering graduate of Lehigh University and a 1987 chemical engineering Ph.D. graduate of the Massachusetts Institute of Technology.
Dr. C. Everett Koop, M.D., graduated from Dartmouth College in 1937 and received his M.D. degree from Cornell Medical College in 1941. After serving an internship at the Pennsylvania Hospital, he pursued postgraduate training at the University of Pennsylvania School of Medicine, the Boston Children's Hospital, and the Graduate School of Medicine at the University of Pennsylvania, where he received the degree of Doctor of Science (Medicine) in 1947. He was named Professor of Pediatric Surgery at the School of Medicine of the University of Pennsylvania in 1959, and later Professor of Pediatrics in 1971. He is presently the Elizabeth DeCamp McInerny Professor at Dartmouth.
An internationally respected pediatric surgeon, Dr. Koop became Surgeon-in-Chief of the Children's Hospital of Philadelphia in 1948 and served in that capacity until 1981. He was the Editor-in-Chief of the Journal of Pediatric Surgery from 1964-1976. Dr. Koop was appointed Deputy Assistant Secretary for Health, U.S. Public Health Service (PHS) in March 1981 and was sworn in as the U.S. Surgeon General on November 17, 1981 where he oversaw the activities of the 6,000 member PHS Commissioned Corps and advised the public on a variety of health matters: smoking, nutrition, environmental health hazards, AIDS and disease prevention. He was also appointed Director of the Office of International Health in May 1982. He resigned as Surgeon General on October 1, 1989 and continues to be a force for public health and health education through his writings, electronic media, public appearances, and as Senior Scholar of the C. Everett Koop Institute at Dartmouth. Dr. Koop has received numerous awards, including the nation's highest civilian award, the Presidential Medal of Freedom, and an Emmy Award for his TV series on health reform. He has written more than 200 articles and books on the practice of medicine and surgery, biomedical ethics, and health policy. In 1991 he was given an Emmy Award in the News and Documentary category for C. Everett Koop, M.D., a five part series on health care reform.
Robert Langer, Ph.D., is one of 13 Institute Professors (the highest honor awarded to a faculty member) at the Massachusetts Institute of Technology (MIT). Dr. Langer has written more than 1,000 articles. He also has more than 600 issued or pending patents worldwide. Dr. Langer's patents have been licensed or sublicensed to over 200 pharmaceutical, chemical, biotechnology and medical device companies. He served as a member of the United States Food and Drug Administration's SCIENCE Board, the FDA's highest advisory board, from 1995-2002 and as its Chairman from 1999-2002. Dr. Langer has received over 160 major awards including the 2006 United States National Medal of Science; the Charles Stark Draper Prize, considered the equivalent of the Nobel Prize for engineers and the 2008 Millennium Prize, the world's largest technology prize. In 1998, he received the Lemelson-MIT prize, the world's largest prize for invention for being "one of history's most prolific inventors in medicine." In 1989 Dr. Langer was elected to the Institute of Medicine of the National Academy of Sciences, and in 1992 he was elected to both the National Academy of Engineering and to the National Academy of Sciences. He is one of very few people ever elected to all three United States National Academies and the youngest in history (at age 43) to ever receive this distinction.
He received his Bachelor's Degree from Cornell University in 1970 and his Sc.D. from the Massachusetts Institute of Technology in 1974, both in Chemical Engineering. To date, Dr. Langer has received honorary doctorates from Yale University, the ETH (Switzerland), the Technion (Israel), the Hebrew University of Jerusalem (Israel), the Universite Catholique de Louvain (Belgium), the University of Liverpool (England), the University of Nottingham (England), Albany Medical College, the Pennsylvania State University, Northwestern University and Uppsala University (Sweden).
Hilary Llewellyn-Thomas, Ph.D., is Professor in the Department of Community & Family Medicine at Dartmouth Medical School (DMS). She serves as Co-Director of the Center for Informed Choice (CIC) in the Dartmouth Institute for Health Policy & Clinical Care (TDI). She also serves as founding Research Director of the Center for Shared Decision Making at Dartmouth-Hitchcock Medical Center. Her research particularly focuses on different approaches to "values clarification", during the process of helping patients make informed, preference-based choices, particularly in close-call situations that generate decisional distress. She also works on the fundamental measurement issues inherent in assessing patients' preferential attitudes about different health states; participation in decision making; the periods of time involved in treatment; and tradeoffs between the different risks & benefits inherent in competing optional therapies. For 10 years, before joining the faculty at Dartmouth in 2000, Dr. Llewellyn-Thomas was a Canadian National Health Research Scholar in the Canadian National Health Research & Development Program. She publishes extensively in the methodological literature about health care decision making. Dr. Llewellyn-Thomas has served as President of the Society for Medical Decision Making (SMDM), and is a recipient of the Society's John M. Eisenberg Award in Recognition of Exemplary Leadership in Practical Application of Medical Decision Making Research.
Terry McGuire, M.S., MBA, is a co-founder and managing general partner of Polaris Venture Partners based in the Boston office. Terry focuses on life sciences investments. Prior to starting Polaris, Terry spent seven years at Burr, Egan, Deleage & Co. investing in early stage medical and information technology companies. Terry began his career in venture capital at Golder, Thoma and Cressey in Chicago. Terry has co-founded three companies: Inspire Pharmaceuticals, Advanced Inhalation Research, Inc., and MicroCHIPS. Terry represents Polaris on the boards of directors of Acceleron Pharma, Biolex Therapeutics, Life Line Screening, Microbia, MicroCHIPS, and Remon Medical Technologies Inc. He has also represented Polaris on the boards of Akamai, Aspect Medical Systems, Cubist Pharmaceuticals, deCODE, GlycoFi and Transform Pharmaceuticals.
In addition to chairing Thayer School's board, Terry also serves on the boards of the Private Equity and Entrepreneurship Center at the Tuck School, Dartmouth College; the National Venture Capital Association; the MIT Center for Cancer Research; the Whitehead Institute for Biomedical Research; and the Advisory Board of the Arthur Rock Center for Entrepreneurship, Harvard Business School. He is a former board member of the Massachusetts Biotechnology Council and MassMEDIC.
Terry holds an MBA from Harvard Business School, an M.S. from Thayer School of Engineering, and a B.S. from Hobart College. He was a Thomas J. Watson Fellow in 1979, studying Gaelic culture in Ireland. Terry is a recipient of the 2005 Albert Einstein Award for Outstanding Achievement in the Life Sciences, awarded by Forbes/Gottlieb Medical Technology Investor, Harvard MIT Biomedical Engineering Center, the New Jerusalem Foundation, the Jerusalem Development Authority, and Rodman and Renshaw.
Dr. Newbower, Ph.D., is Co-founder, Strategic Director and Chief Technology Officer of CIMIT, an innovative multi-institutional $12M-per-year Center designed to accelerate the development of cost-effective medical technologies. As the former Vice President for Research Management of Partners HealthCare, which includes the Massachusetts General Hospital, the Brigham and Women's Hospital, McLean Hospital and Spaulding Rehabilitation Hospital, he dealt with all the corporate issues related to support of their unique biomedical research programs, comprising $900M/year in aggregate. He holds faculty appointments in the Harvard-MIT Division of Health Sciences and Technology (HST) and in the Harvard Medical School, and his academic activities include work on development of minimally invasive technologies, and on implementation of new systems technologies in the healthcare system. His past work includes leading the Bioengineering group at MGH which conducted pioneering studies, 30 years ago, of human error in medical care. Research concepts of his have led to the development of several high-technology physiologic-monitoring products used worldwide in anesthesia and intensive care.
With a Bachelors degree from MIT, he holds a Ph.D. from Harvard University in solid-state physics. Honors include the Arnold O. Beckman Award for Innovation from the Instrument Society of America, The AAMI Becton-Dickenson Career Achievement Award, election as Sr. Member in IEEE, and election as a Fellow in the American Institute of Medical and Biological Engineering.
Dr. Randolph Noelle, Ph.D., is a Professor in the Department of Microbiology and Immunology, Director of the Immunology Program of the Norris Cotton Cancer Center and an adjunct member of the Department of Biochemistry.
In 1984, he joined the faculty at Dartmouth Medical School. In 1991, Dr. Noelle's laboratory identified a novel membrane protein expressed on helper T lymphocytes (Th), CD154. This ligand, and its receptor, CD40 play a central role in regulating the development of both humoral and cell-mediated immunity. Currently, five areas of active investigation are underway in relation to this ligand-receptor pair: 1) the molecular basis for CD40 signaling, 2) the role of this and other immune mediators in inflammation in the central nervous system, 3) regulation and development of B cell memory and plasma cells, 4) the role of CD154 in immune tolerance to transplanted tissues and organs, and 5) the translational development of CD154 for the treatment of autoimmunity and graft rejection.
Dr. Noelle received his Ph.D. from Albany Medical College 1980, and was a Post-doctoral Fellow at the University of Texas Health Science Center at Dallas from 1980-84.
Dr. Keith D. Paulsen, Ph.D., is the Robert A. Pritzker Chair in Biomedical Engineering at the Thayer School of Engineering at Dartmouth, Professor of Radiology at Dartmouth Medical School, Director of the Advanced Imaging Center at Dartmouth-Hitchcock Medical Center and Co-Director of the Cancer Imaging and Radiobiology Research Program at the Norris Cotton Cancer Center. He is an Associate Editor of the IEEE Transactions on Medical Imaging. His research specializes in cancer imaging techniques in the breast and brain. Dr Paulsen has published over 200 articles in the peer-reviewed scientific and medical literature and has received numerous awards for funding his research from the National Institutes of Health.
He has maintained an active research program with funding from the NIH for more than twenty years that is currently focused on the development and evaluation of imaging methods for diagnostic and therapeutic clinical decision-making in the identification and management of cancers, primarily of the breast and brain. Dr Paulsen served as a member of the Radiation Research Study Section from 1996-2000 and the Biomedical Imaging Technology Study Section from 2002-2006 within the Center for Scientific Review at the NIH. He has published more than 200 peer-reviewed journal articles in medical engineering, physics and clinical literature.
Dr. Paulsen received the B.S. degree in Biomedical Engineering from Duke University in 1981 and the M.S. and Ph.D. degrees in 1984 and 1986, respectively, from Dartmouth where he studied advanced computational methods for biomedical modeling of cancer treatments. He was an Assistant Professor in the Department of Electrical Engineering with a joint appointment in Radiation Oncology in the Health Sciences Center at the University of Arizona from 1986 to 1988. Dr. Paulsen returned to Dartmouth where he became an Associate and then Full Professor of Engineering Sciences in 1994 and 2000, respectively.
Roderic Pettigrew, M.D., Ph.D., is the first director of the National Institute of Biomedical Imaging and Bioengineering. Prior to his appointment, he was a Professor of Radiology Medicine (Cardiology) at Emory University, as well as Professor of Bioengineering at the Georgia Institute of Technology. He also served as Director of the Emory Center for Magnetic Resonance (MR) Research at Emory University School of Medicine in Atlanta, Georgia.
Dr. Pettigrew is known for his pioneering research at Emory University involving four-dimensional imaging of the heart using MR. He graduated cum laude with a B.S. in Physics from Morehouse College where he was a Merrill Scholar. He received an M.S. in Nuclear Science and Engineering from Rensselaer Polytechnic Institute, and he received a Ph.D. in Applied Radiation Physics from the Massachusetts Institute of Technology as a Whitaker Harvard-MIT Health Sciences Scholar. Subsequently, he received an M.D. from the University of Miami School of Medicine in an accelerated two-year program, served an internship and residency in Internal Medicine at Emory University, and completed his residency in Nuclear Medicine at the University of California, San Diego. Dr. Pettigrew then spent a year as a Clinical Research Scientist with Picker International, the first manufacturer of MR equipment. In 1985, he joined Emory as a Robert Wood Johnson Foundation Fellow focusing in non-invasive cardiac imaging.
Dr. Pettigrew's awards include membership in Phi Beta Kappa, the Bennie Award (Benjamin E. Mays) for Achievement, and he was named the Most Distinguished Alumnus of the University of Miami. In 1989, when the Radiological Society of North America met to celebrate its 75th (Diamond) Anniversary, Dr. Pettigrew was selected to give the keynote Eugene P. Pendergrass New Horizons Lecture. He has served as Chairman of the Diagnostic Radiology Study Section for the Center for Scientific Review at NIH, and has been elected to membership in the Institute of Medicine and fellowships in the American Heart Association, the American College of Cardiology, the American Institute for Medical and Biological Engineering, the International Society for Magnetic Resonance in Medicine, and the Biomedical Engineering Society.
Brian W. Pogue, Ph.D., is Dean of Graduate Studies at Dartmouth College and a Professor of Engineering Sciences at the Thayer School of Engineering at Dartmouth. He holds a Research Scientist appointment through the Wellman Center for Photomedicine at the Massachusetts General Hospital, and has published over 300 papers and abstracts in the areas of biomedical optics, diffuse spectral tomography, breast cancer and photodynamic therapy of cancer. His research focuses on applications of biomedical optics in imaging and treatment of cancer. The work is funded through two program grants and several individual grants from the National Cancer Institute.
He is Deputy Editor for the journal Optics Letters for the OSA. He is also on the editorial boards of Medical Physics, the Journal of Biomedical Optics, and the Journal of Photochemistry and Photobiology B, and is a Program Chair for the upcoming European Conference on Biomedical Optics, in June 2009 in Munich.
Dr. Pogue graduated with B.Sc. Honors and M.Sc degrees in Physics from York University in Canada, and a Ph.D. in Medical Physics from McMaster University, in Canada. Following this he became a Research Fellow at the Harvard Medical School in the Wellman Center for Photomedicine.
At Dartmouth Dr. Pogue teaches classes in Medical Imaging, Electrical Engineering and the Ph.D. Professional Workshops, training graduating doctoral students about how to prepare for life after graduation in academia and industry.
Peter J. Robbie, M.F.A., is a product designer, Associate Professor of Engineering and Lecturer in the Department of Engineering Sciences at Dartmouth.
Robbie's research focus is medical imaging and treatment planning. He was a co-founder of Medical Media Systems (MMS) where he was senior vice president for product design and clinical affairs. MMS (now M2S) is an industry leader in cutting-edge imaging technology for treatment planning. The MMS team designed and developed an advanced imaging system, Preview Treatment Planning Software, which received FDA and HICFA approvals for advanced minimally invasive procedures such as endovascular repair of aortic aneurysms. Recently he has been a consultant on the design team for the MIST Project, a microwave imaging system for detection of breast cancer.
At Dartmouth Robbie teaches product design, creative problem solving, and design for human use. He received an M.F.A. from Cornell University (1972) and for several years taught three-dimensional design in the Visual Studies program at Dartmouth. He is a professional member of the Industrial Design Society of America (IDSA) and has served as a design consultant for several corporations.
Michael J. Ross, Ph.D., is a general partner at SV Life Sciences, an international venture capital fund focused exclusively in the life sciences, and is the US partner leading the therapeutics team. Mike graduated from his A.B. degree at Dartmouth in 1971 and completed his Ph.D. at the California Institute of Technology. Prior to joining SV Life Sciences, Michael was the tenth employee at Genentech where he worked for 13 years. He served as Genentech team leader for Humulin® (human insulin-Lilly), Roferon® (Interferon alpha -Roche), Protropin® (hGH), and as Vice President of Development during the development of Activase®, Nutropin® and Pulmozyme®. Michael then started Genentech's protein engineering and small molecule discovery effort as Vice President of Medicinal and Biomolecular Chemistry. Michael was the Founding CEO of Arris Pharmaceutical (now part of Celera), MetaXen (now part of Exelixis), ExSAR and CyThera (now part of Novocell). Michael was most recently Managing Partner in Didyma, LLC, a biotechnology management consulting firm.
Julie A. Shimer, Ph.D., is President & CEO of Welch Allyn, a leading global manufacturer of medical diagnostic equipment and a complete range of digital and connected solutions. She worked at AT&T Bell labs from 1982 to 1992, staring as a member of the technical staff, and ending up as the Department Head for VLSI Process Development. From 1993 to 2000 she worked at Motorola Inc. as Vice President and General Manager for several divisions. From 2001 to 2007 she was President and CEO of Vocera Communications, prior to her current position at Welch Allyn. She is a Senior Member of the IEEE and Society of Women Engineers; member of Sigma Xi, on the Board of Directors of the Engineering Information Foundation, and the Consumer Electronics Association. She sits on the National Medal of Technology Nomination Evaluation Committee, as well as the Motorola Scientific Advisory Board
She completed her B.S. in Physics at the Rensselaer Polytechnic Institute, followed by M.S. and Ph.D. degrees at Lehigh University in Electrical Engineering.
Robert Sprinkle, M.D., Ph.D., is a physician and policy scholar. He studied history at Dartmouth College and medicine at the University of Cincinnati. He trained clinically at the University of Virginia and the University of Texas Southwestern Medical Center, Dallas, and is a diplomate of both the American Board of Family Medicine and the American Board of Pediatrics and a Fellow of the respective academies. In Dallas he served three years as a family-medicine residency-program director and as an attending physician in three disciplines. He moved to the Woodrow Wilson School of Public and International Affairs, Princeton University, to earn a second doctorate, the Ph.D. While enrolled at the Wilson School, he was for two years a Social Science Research Council MacArthur Foundation Fellow in International Peace and Security and for two months a refugee-camp physician. Subsequently, at Duke University, he held clinical, policy-studies, and applied-ethics positions and staffed federal clinical-practice guideline panels for sickle cell disease and unstable angina. He was recruited to the University of Maryland School of Public Policy in 1995 and was promoted to a tenured associate professorship in 2001. At Maryland he has created and taught graduate and honors-undergraduate courses across the full range of his policy interests. He is the author or coauthor of papers in clinical medicine, bioethics, health policy, bioengineering, environmental policy, political philosophy, international relations, and biosecurity. He is the author of the book, Profession of Conscience: The Making and Meaning of Life-Sciences Liberalism (Princeton University Press, 1994), an intellectual history of political-ethical thought in the life sciences. He was Editor-in-Chief of Politics and the Life Sciences for two terms, from 2001 through 2007; in 2008 he became Contributing Editor for Electronic Publishing. He spent the 2007-2008 academic year on sabbatical at Dartmouth, where he held visiting positions in Ethics, in Public Policy, and in Pediatrics.
Anna Tosteson, Sc.D., is a Professor of Medicine and of Community and Family Medicine at Dartmouth Medical School, Associate Director for Dartmouth's Multidisciplinary Clinical Research Center in Musculoskeletal Diseases, and a faculty member of The Dartmouth Institute for Health Policy and Clinical Practice. She did her undergraduate studies at Cornell and her graduate studies at Harvard, where she studied biostatistics and health decision science. Her research uses decision-analytic modeling, economic evaluation and preference-based measures of health-related quality of life to address clinical and health policy issues in osteoporosis/musculoskeletal diseases and women's health. She is an active participant in national and international groups that focus on the economic evaluation of both new and established health care technologies including the American College of Radiology Imaging Network. She teaches in The Dartmouth Institute for Health Policy and Clinical Practice's degree programs.
Milton C. Weinstein, Ph.D., is the Henry J. Kaiser Professor of Health Policy and Management at the Harvard School of Public Health and Professor of Medicine at the Harvard Medical School. At the Harvard School of Public Health he is Academic Director of the Program in Health Decision Science, and Director of the Program on Economic Evaluation of Medical Technology. He is currently also Visiting Professor in the Department of Economics and Visiting Scholar in The Dartmouth Institute for Health Policy and Clinical Practice. He is best known for his research on cost-effectiveness of medical practices and for developing methods of economic evaluation and decision analysis in health care. He is a co-developer of the CEPAC (Cost-Effectiveness of Preventing AIDS Complications) computer simulation model, and has conducted studies on prevention and treatment of HIV infections. He is the co-developer of the Coronary Heart Disease Policy Model, which has been used to evaluate the cost-effectiveness of cardiovascular prevention and treatment. He is an author of four books: Decision Making in Health and Medicine: Integrating Evidence and Values; Cost-Effectiveness in Health and Medicine, the report of the Panel of Cost Effectiveness in Health and Medicine; Clinical Decision Analysis; and Hypertension: A Policy Perspective. He has also published more than 200 papers in peer-reviewed medical, public health, and economics journals. He is an elected member of the Institute of Medicine of the National Academy of Sciences, and a recipient of the Award for Career Achievement from the Society for Medical Decision Making. Dr. Weinstein received his A.B. and A.M. in Applied Mathematics (1970), his M.P.P. (1972), and his Ph.D. in Public Policy (1973) from Harvard University.
Michael Zubkoff is Professor and Chair of the Department of Community and Family Medicine at Dartmouth Medical School, Professor of Economics and Management at the Tuck School of Business at Dartmouth, and Director of the MD-MBA Program at Dartmouth.
The faculty of the Department of Community and Family Medicine, which he has chaired since 1975, have the largest sponsored research budget of any such department in the nation (annual budget of over $35 million - direct costs only), and were cited by the U.S. Liaison Committee on Medical Education for their "excellence in academic pursuits and community-based teaching ... made all the more prominent by their wide ranging nationally recognized research programs." Professor Zubkoff was elected to membership in the National Academy of Sciences' Institute of Medicine in 1983, and has been profiled in Who's Who in America each year since 1976. He has been the recipient of two honorary degrees and has served on the board of directors of a number of foundations and corporations. For the past 23 years he has served as a correspondent for the Committee on Human Rights of the National Academy of Sciences.
After completing his training and studies at Columbia University Professor Zubkoff served, from 1967-1975, as Vice Chairman of the Department of Family and Community Health at Meharry Medical College, and Assistant/Associate Professor of Economics and Director of the Health Services Research Training Programs (Ph.D. and Masters) at Vanderbilt University, in Nashville, Tennessee. During 1967-1969 he also taught at Fisk University under the Woodrow Wilson Fellowship Foundation's Teaching Fellows Program. Throughout this period he served in a number of positions (including President, Vice President and Treasurer) within the Medical Committee for Human Rights' southern branch which among it's many initiatives coordinated medical coverage at the Civil Rights Marches being led by Dr. Martin Luther King, Jr., throughout the south.
In 1974, Professor Zubkoff was asked by President Ford to serve as rapporteur for the Department of Health, Education and Welfare (HEW) PreSumit Conference on Inflation in Health Care, and to personally present the HEWs PreSumit Conference recommendations to President Ford, his economic advisors, leaders of congress and delegates, during the nationally televised White House Summit on Inflation. He has served as an advisor and/or consultant to the White House staffs of Presidents' Ford, Carter, Reagan, Bush, Clinton and Bush, leaders of the U.S. House and Senate and corporate executives throughout the world.
During the late 1980's Professor Zubkoff was co-founder together with Drs. Tarlov, Ware, Greenfield, Nelson, and Perrin of the Medical Outcomes Study (MOS) based at RAND Corp, and has served since then as a member of the MOS Steering Committee, which oversees and monitors all analyses and publications. He was recipient of the Association for Health Services Research (AHSR) 1993 Article of the Year Award for two of the Medical Outcomes Study articles he co-authored on "Variations in Resource Utilization Among Medical Specialties and Systems of Care" and "Differences in the Mix of Patients Among Medical Specialties and Systems of Care," which appeared in the Journal of the American Medical Association.
Professor Zubkoff currently directs the Dartmouth MD-MBA Program, teaches courses on Medical Care Organization, Economics and Management in the Amos Tuck School of Business Administration's MBA Program and Dartmouth's Center for the Evaluative Clinical Sciences' MPH, M.S. & Ph.D. Programs, and co-directs the 4th year required medical student course Health, Society and the Physician, and was recently asked to serve as a member of the National Academy of Sciences/Institute of Medicine/National Research Council's Board on Children, Youth and Families.